183 related articles for article (PubMed ID: 34952790)
1. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer.
Bae J; Yang SH; Kim A; Kim HG
Urol Oncol; 2022 Mar; 40(3):105.e1-105.e10. PubMed ID: 34952790
[TBL] [Abstract][Full Text] [Related]
2. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
4. miRNAs as biomarkers in prostate cancer.
Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
[TBL] [Abstract][Full Text] [Related]
5. tRNA-halves are prognostic biomarkers for patients with prostate cancer.
Zhao C; Tolkach Y; Schmidt D; Muders M; Kristiansen G; Müller SC; Ellinger J
Urol Oncol; 2018 Nov; 36(11):503.e1-503.e7. PubMed ID: 30209018
[TBL] [Abstract][Full Text] [Related]
6. The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review.
Vazquez-Urrutia JR; Torres-Bustamante MI; Cerda-Cruz CR; Bravo-Cuellar A; Ortiz-Lazareno PC
Future Oncol; 2023 Jan; 19(1):77-93. PubMed ID: 36705257
[TBL] [Abstract][Full Text] [Related]
7. Urinary RNA-based biomarkers for prostate cancer detection.
Martignano F; Rossi L; Maugeri A; Gallà V; Conteduca V; De Giorgi U; Casadio V; Schepisi G
Clin Chim Acta; 2017 Oct; 473():96-105. PubMed ID: 28807541
[TBL] [Abstract][Full Text] [Related]
8. Innovative biomarkers for prostate cancer early diagnosis and progression.
You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
[TBL] [Abstract][Full Text] [Related]
9. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
10. [New progress in prostate cancer biomarker research].
Qu M; Ren S; Sun Y
Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):317-20. PubMed ID: 26269169
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
12. Use of thymosin beta15 as a urinary biomarker in human prostate cancer.
Hutchinson LM; Chang EL; Becker CM; Shih MC; Brice M; DeWolf WC; Gaston SM; Zetter BR
Prostate; 2005 Jul; 64(2):116-27. PubMed ID: 15666387
[TBL] [Abstract][Full Text] [Related]
13. Circulating RNAs in prostate cancer patients.
Mugoni V; Ciani Y; Nardella C; Demichelis F
Cancer Lett; 2022 Jan; 524():57-69. PubMed ID: 34656688
[TBL] [Abstract][Full Text] [Related]
14. Emerging biomarkers for the diagnosis and prognosis of prostate cancer.
Sardana G; Dowell B; Diamandis EP
Clin Chem; 2008 Dec; 54(12):1951-60. PubMed ID: 18927246
[TBL] [Abstract][Full Text] [Related]
15. HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer.
Pipinikas CP; Carter ND; Corbishley CM; Fenske CD
Biomarkers; 2008 Nov; 13(7):680-91. PubMed ID: 19096962
[TBL] [Abstract][Full Text] [Related]
16. Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Sankanagoudar S; Sharma H; Choudhary GR; Pareek P; Vishnoi JR; Sharma P
Urol Oncol; 2020 Dec; 38(12):918-928. PubMed ID: 32622720
[TBL] [Abstract][Full Text] [Related]
17. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B
Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarkers of prostate cancer.
Fujita K; Nonomura N
Int J Urol; 2018 Sep; 25(9):770-779. PubMed ID: 30129068
[TBL] [Abstract][Full Text] [Related]
19. Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.
Davey M; Benzina S; Savoie M; Breault G; Ghosh A; Ouellette RJ
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172003
[TBL] [Abstract][Full Text] [Related]
20. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
